Form 8-K - Current report:
SEC Accession No. 0001628280-21-013446
Filing Date
2021-07-02
Accepted
2021-07-02 16:15:43
Documents
16
Period of Report
2021-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cerc-20210702.htm   iXBRL 8-K 43113
2 EX-1.1 ex-11atmxsalesagreement.htm EX-1.1 304303
3 EX-5.1 ex-51opinion2021atm.htm EX-5.1 17928
4 EX-99.1 ex-991supplementalriskfact.htm EX-99.1 4194
8 troutmanlogoa.jpg GRAPHIC 3949
  Complete submission text file 0001628280-21-013446.txt   573269

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20210702.xsd EX-101.SCH 1949
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20210702_lab.xml EX-101.LAB 23312
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20210702_pre.xml EX-101.PRE 12151
9 EXTRACTED XBRL INSTANCE DOCUMENT cerc-20210702_htm.xml XML 9975
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37590 | Film No.: 211070246
SIC: 2834 Pharmaceutical Preparations